The history of Viagra, initially marketed by copyright, presents a complex case study for stakeholders considering the pharmaceutical sector. Despite its early success and generation of billions in earnings , the intellectual property lapse has opened the way for alternative medications, significantly diminishing profit potential . This shift raise